Vaxxinova GmbH, originally established in Cuxhaven, Germany, and locations in Norway and Japan, decided to open their international headquarters in Nijmegen, the Netherlands, together with a new research laboratory.

The first employees began to arrive, and in mid-2017 the location at the Novio Tech Campus Nijmegen will be fully operational. Expectations are within three years there will be at least 30 employees at this location, doing high-value vaccine research in addition to headquarter functions.

Vaxxinova is a part of the German family-owned EW Group, active in the nutrition sector. This fast-growing, multinational business has expertise in research related to genetics and the food industry. In various subsets of this industry they are global market leader. Vaxxinova develops, produces and sels a wide range of innovative vaccines to protect livestock and fish stocks from disease. They create high-value solutions to improve the health of feed animals, and support the client’s business when it comes to veterinary medicine. Vaxxinova combines modern facilities with more than 20 years of experience and has a worldwide network with deep scientific expertise.


Oost NL helped with Vaxxinova’s choice of location and brought them in contact with various parties in the Netherlands in order to help them achieve their long-term goals regarding effective research.